Inhibitor Therapeutics, Inc.
INTI
Revenue
0.00
0.000.00%
3 Months ChangeAssets
7.17M
▼-620.85k▼-7.97%
3 Months ChangeLiabilities
3.04M
▼-120.32k▼-3.81%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0001493152-24-030381
2024-05-13
Form 10-Q
ID: 0001493152-24-018805
2023-12-14
Form 8-K
ID: 0001193125-23-294696
2023-11-13
Form 10-Q
ID: 0001493152-23-040351
2023-10-18
Form 8-K
ID: 0001193125-23-258156
2023-08-29
Form 8-K
ID: 0001193125-23-223590
2023-08-11
Form 10-Q
ID: 0001493152-23-027740
2023-05-31
Form 8-K
ID: 0001493152-23-019651
2023-05-15
Form 10-Q
ID: 0001493152-23-016967
2022-12-19
Form 8-K
ID: 0001193125-22-308415